258
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia

ORCID Icon
Pages 117-127 | Received 08 Mar 2023, Accepted 11 Jul 2023, Published online: 19 Jul 2023

References

  • North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med. 1988;319(15):983–989. doi:10.1056/NEJM198810133191505
  • D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–231. doi:10.1016/j.jhep.2005.10.013
  • Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266–272. doi:10.1016/S0168-8278(02)00420-8
  • De Franchis R, Baveno V. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743‐752. doi:10.1016/j.jhep.2015.05.022
  • Ben-Menachem T, Decker GA, Early DS, et al. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012;76(4):707–718. doi:10.1016/j.gie.2012.03.252
  • Robic MA, Procopet B, Metivier S, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55(5):1017–1024. doi:10.1016/j.jhep.2011.01.051
  • Abraldes JG, Bureau C, Stefanescu H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study. Hepatology. 2016;64(6):2173–2184. doi:10.1002/hep.28824
  • Augustin S, Pons M, Maurice JB, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66(6):1980–1988. doi:10.1002/hep.29363
  • Bae J, Sinn DH, Kang W, et al. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38(8):1442–1448. doi:10.1111/liv.13732
  • Cheng F, Cao H, Liu J, et al. Meta-analysis of the accuracy of transient elastography in measuring liver stiffness to diagnose esophageal varices in cirrhosis. Medicine. 2018;97(28):e11368. doi:10.1097/MD.0000000000011368
  • Berzigotti A, Tsochatzis E, Boursier J, et al. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J Hepatol. 2021;75(3):659–689. doi:10.1016/j.jhep.2021.05.025
  • European Association for Study of Liver. Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237–264. doi:10.1016/j.jhep.2015.04.006
  • Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American gastroenterological association institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 2017;152(6):1544–1577. doi:10.1053/j.gastro.2017.03.016
  • Alswat K, Alanazi M, Bashmail A, et al. Validation of the EVendo score for the prediction of varices in cirrhotic patients. Saudi J Gastroenterol. 2022;28(5):378–384. doi:10.4103/sjg.sjg_624_21
  • Fallatah HI, Al Nahdi H, Al Khatabi M, et al. Variceal hemorrhage: Saudi tertiary center experience of clinical presentations, complications and mortality. World J Hepatol. 2012;4(9):268–273. doi:10.4254/wjh.v4.i9.268
  • Gado AS, Ebeid BA, Abdelmohsen AM, et al. Clinical Outcome of Acute Upper Gastrointestinal Hemorrhage among Patients Admitted to a Government Hospital in Egypt. Saudi J Gastroenterol. 2012;18(1):34–39. doi:10.4103/1319-3767.91737
  • Maurice JB, Brodkin E, Arnold F, et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol. 2016;65(5):899–905. doi:10.1016/j.jhep.2016.06.021
  • Stafylidou M, Paschos P, Katsoula A, et al. Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(9):1744–1755.e11. doi:10.1016/j.cgh.2019.04.062
  • Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018;69(4):878–885. doi:10.1016/j.jhep.2018.05.019
  • Ding NS, Nguyen T, Iser DM, et al. Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices. Liver Int. 2016;36(2):240–245. doi:10.1111/liv.12916